Literature DB >> 10191263

Independent regulation of cyclo-oxygenase 2 expression by p42/44 mitogen-activated protein kinases and Ca2+/calmodulin-dependent kinase.

M Goppelt-Struebe1, A Hahn, M Stroebel, C O Reiser.   

Abstract

5-Hydroxytryptamine (5-HT, 'serotonin') is a potent inducer of the early response gene cyclo-oxygenase 2 (Cox-2; prostaglandin G/H synthase) in mesangial cells. Protein kinase C (PKC), Ca2+-dependent enzymes and mitogen-activated protein kinase (p42/44 MAPK) have previously been shown to be essential modules of the signalling pathway leading from the pertussis-insensitive 5-HT2A receptor to the induction of Cox-2 mRNA expression. In the present study, PKC activation was linked to the 5-HT-mediated phosphorylation and thus the activation of p42/44 MAPK: the inhibition of PKC by the specific inhibitor GF109203x prevented p42/44 MAPK activation. Ca2+/calmodulin-dependent (CaM) kinase II delta2 was detected in mesangial cells by Western blot analysis. The inhibition of CaM kinase by the inhibitors KN62 or KN93 led to a partial inhibition of 5-HT-induced Cox-2 mRNA expression and decreased basal, but not PMA-mediated, Cox-2 expression. The 5-HT-mediated activation of MAPK was not decreased by KN62 or KN93, excluding CaM kinase as a signalling module upstream of p42/44 MAPK. Taken together, these results indicate a modulatory involvement of CaM kinase in the regulation of 5-HT-mediated Cox-2 mRNA expression in addition to the main pathway that consists of the activation of PKC and p42/44 MAPK.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10191263      PMCID: PMC1220161     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

Review 1.  Molecular pharmacology of calmodulin pathways in the cell functions.

Authors:  H Hidaka; T Ishikawa
Journal:  Cell Calcium       Date:  1992 Jun-Jul       Impact factor: 6.817

2.  The newly synthesized selective Ca2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells.

Authors:  M Sumi; K Kiuchi; T Ishikawa; A Ishii; M Hagiwara; T Nagatsu; H Hidaka
Journal:  Biochem Biophys Res Commun       Date:  1991-12-31       Impact factor: 3.575

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Signaling pathways mediating induction of the early response genes prostaglandin G/H synthase-2 and egr-1 by serotonin via 5-HT2A receptors.

Authors:  M Goppelt-Struebe; M Stroebel
Journal:  J Cell Physiol       Date:  1998-06       Impact factor: 6.384

5.  Stimulation of rat mesangial cell proliferation by macrophage interleukin 1.

Authors:  D H Lovett; J L Ryan; R B Sterzel
Journal:  J Immunol       Date:  1983-12       Impact factor: 5.422

6.  KN-62, 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenylpiperazi ne, a specific inhibitor of Ca2+/calmodulin-dependent protein kinase II.

Authors:  H Tokumitsu; T Chijiwa; M Hagiwara; A Mizutani; M Terasawa; H Hidaka
Journal:  J Biol Chem       Date:  1990-03-15       Impact factor: 5.157

7.  Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976.

Authors:  G Martiny-Baron; M G Kazanietz; H Mischak; P M Blumberg; G Kochs; H Hug; D Marmé; C Schächtele
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

8.  The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.

Authors:  D Toullec; P Pianetti; H Coste; P Bellevergue; T Grand-Perret; M Ajakane; V Baudet; P Boissin; E Boursier; F Loriolle
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

9.  Calcium-regulated phosphorylation within the leucine zipper of C/EBP beta.

Authors:  M Wegner; Z Cao; M G Rosenfeld
Journal:  Science       Date:  1992-04-17       Impact factor: 47.728

Review 10.  The multifunctional Ca2+/calmodulin-dependent protein kinases.

Authors:  H Schulman
Journal:  Curr Opin Cell Biol       Date:  1993-04       Impact factor: 8.382

View more
  6 in total

1.  Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.

Authors:  Jie Xu; Bo Jian; Richard Chu; Zhibin Lu; Quanyi Li; John Dunlop; Sharon Rosenzweig-Lipson; Paul McGonigle; Robert J Levy; Bruce Liang
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  The platelet-derived-growth-factor receptor, not the epidermal-growth-factor receptor, is used by lysophosphatidic acid to activate p42/44 mitogen-activated protein kinase and to induce prostaglandin G/H synthase-2 in mesangial cells.

Authors:  M Goppelt-Struebe; S Fickel; C O Reiser
Journal:  Biochem J       Date:  2000-01-15       Impact factor: 3.857

3.  Prostaglandin E2 affects differently the release of inflammatory mediators from resident macrophages by LPS and muramyl tripeptides.

Authors:  P Dieter; U Hempel; S Kamionka; A Kolada; B Malessa; E Fitzke; T A Tran-Thi
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

4.  Ca2+-mediated activation of ERK in hepatocytes by norepinephrine and prostaglandin F2 alpha: role of calmodulin and Src kinases.

Authors:  Oyvind Melien; Laila S Nilssen; Olav F Dajani; Kristin Larsen Sand; Jens-Gustav Iversen; Dagny L Sandnes; Thoralf Christoffersen
Journal:  BMC Cell Biol       Date:  2002-02-20       Impact factor: 4.241

5.  Radix Paeoniae Rubra and Radix Paeoniae Alba Attenuate CCl4-induced acute liver injury: an ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) based metabolomic approach for the pharmacodynamic study of Traditional Chinese Medicines (TCMs).

Authors:  Rui Wang; Ai-Zhen Xiong; Zhong-Qiu Teng; Qi-Wei Yang; Yan-Hong Shi; Li Yang
Journal:  Int J Mol Sci       Date:  2012-11-09       Impact factor: 5.923

Review 6.  Psychedelics and Immunomodulation: Novel Approaches and Therapeutic Opportunities.

Authors:  Attila Szabo
Journal:  Front Immunol       Date:  2015-07-14       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.